Cryo Cell International (CCEL) Revenue (2010 - 2026)

Cryo Cell International has disclosed Revenue across 17 years of filings, most recently posting $7.7 million for Q1 2026.

• In Q1 2026, Revenue fell 3.59% year-over-year to $7.7 million; the TTM figure through Feb 2026 stood at $31.3 million (down 2.56% YoY), while the FY2025 annual figure was $31.6 million, down 1.31% from the prior year.
• Revenue eased to $7.7 million in Q1 2026, from $7.8 million in the prior quarter.
• Over the last five years, Revenue for CCEL reached as high as $8.1 million in Q3 2024 and fell as low as $7.3 million in Q1 2022.
• The 5-year median for Revenue is $7.8 million (2025), against an average of $7.8 million.
• Annual changes were most pronounced in 2023 — Revenue climbed 7.8% — and 2026, when it retreated 3.59%.
• A 5-year view of Revenue shows it stood at $7.8 million in 2022, then advanced by 1.45% to $7.9 million in 2023, then grew by 1.87% to $8.0 million in 2024, then decreased by 2.26% to $7.8 million in 2025, then dropped by 2.04% to $7.7 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $7.7 million, $7.8 million, and $7.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.